-
ERNA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Eterna Therapeutics (ERNA)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 4.26 mm | 4.26 mm | 4.26 mm | 4.26 mm | 4.26 mm | 4.26 mm |
Cash burn (monthly) | 1.65 mm | 139.00 k | 8.86 mm | 3.75 mm | (no burn) | (no burn) |
Cash used (since last report) | 4.60 mm | 387.80 k | 24.73 mm | 10.46 mm | n/a | n/a |
Cash remaining | -336.63 k | 3.88 mm | -20.47 mm | -6.20 mm | n/a | n/a |
Runway (months of cash) | -0.2 | 27.9 | -2.3 | -1.7 | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 15 |
Opened positions | 2 |
Closed positions | 14 |
Increased positions | 1 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 193.61 mm |
Total shares | 7.34 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Factor Bioscience | 4.22 mm | $0.00 |
Custard & Pitts Investment | 1.40 mm | $0.00 |
Freebird Partners | 1.05 mm | $2.96 mm |
Nicholas Jason Singer | 280.42 k | $648.00 k |
Purchase Capital | 280.42 k | $974.00 k |
Cypress Point Wealth Management | 94.38 k | $172.71 mm |
Baldwin Brothers | 8.54 k | $15.64 mm |
Montag A & Associates | 212.00 | $388.00 k |
MS Morgan Stanley | 50.00 | $92.00 k |
Activest Wealth Management | 50.00 | $92.00 k |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Oct 24 | Charles Cherington | Common Stock | Conversion | Acquire C | No | No | 0.5 | 2,819,546 | 1.41 mm | 16,628,123 |
29 Oct 24 | Charles Cherington | Common Stock | Buy | Acquire P | No | No | 0 | 1,562,988 | 0.00 | 13,808,577 |
29 Oct 24 | Charles Cherington | Common Stock | Buy | Acquire P | No | No | 0 | 5,420,823 | 0.00 | 12,245,589 |
29 Oct 24 | Charles Cherington | Common Stock | Buy | Acquire P | No | No | 0 | 1,237,762 | 0.00 | 6,824,766 |
29 Oct 24 | Charles Cherington | Common Stock | Buy | Acquire P | No | No | 0 | 4,768,783 | 0.00 | 5,587,004 |
29 Oct 24 | Charles Cherington | Common Stock | Buy | Acquire P | No | No | 0 | 261,756 | 0.00 | 818,221 |
29 Oct 24 | Charles Cherington | Warrants Common Stock | Sell | Dispose S | No | No | 1.43 | 3,125,976 | 4.47 mm | 0 |
29 Oct 24 | Charles Cherington | Warrants Common Stock | Sell | Dispose S | No | No | 1.43 | 2,475,524 | 3.54 mm | 0 |
29 Oct 24 | Charles Cherington | Warrants Common Stock | Sell | Dispose S | No | No | 1.43 | 523,512 | 748.62 k | 0 |
23 Sep 24 | Charles Cherington | Warrants Common Stock | Buy | Acquire P | No | No | 1.43 | 83,916 | 120.00 k | 2,475,524 |